BRIEF published on 02/13/2025 at 07:05, 1 year 6 months ago SCHOTT Pharma Begins Fiscal Year 2025 with Promising Results Revenue Growth EBITDA Margin Q1 Results High-value Solutions DCS Segment
BRIEF published on 02/13/2025 at 07:05, 1 year 6 months ago SCHOTT Pharma débute l'année fiscale 2025 avec des résultats prometteurs Marge EBITDA Croissance Des Revenus Résultats Du Premier Trimestre Des Solutions À Haute Valeur Ajoutée Segment DCS
PRESS RELEASE published on 02/13/2025 at 07:00, 1 year 6 months ago SCHOTT Pharma records good start into fiscal year and confirms full year outlook SCHOTT Pharma reports good start in Q1 2025 with EUR 230m revenues, confirms full year outlook. EBITDA margin at 25.1% as reported. High-value solutions share at 55% Revenues EBITDA Margin SCHOTT Pharma Full Year Outlook Q1 2025
BRIEF published on 02/04/2025 at 18:27, 1 year 6 months ago SCHOTT Pharma Holds Successful Annual General Meeting Annual General Meeting Shareholder Approval SCHOTT Pharma Profit Growth MDAX Promotion
BRIEF published on 02/04/2025 at 18:27, 1 year 6 months ago SCHOTT Pharma organise avec succès son assemblée générale annuelle SCHOTT Pharma Assemblée Générale Annuelle Approbation Des Actionnaires Croissance Des Bénéfices Promotion MDAX
PRESS RELEASE published on 02/04/2025 at 18:22, 1 year 6 months ago SCHOTT Pharma with successful Annual General Meeting: Shareholders approve all agenda items SCHOTT Pharma's successful Annual General Meeting for FY 2024 with all agenda items approved by shareholders, including new Supervisory Board member Dr. Wolfram Carius and KPMG as new auditor Annual General Meeting Shareholders SCHOTT Pharma KPMG Dr. Wolfram Carius
BRIEF published on 12/12/2024 at 07:05, 1 year 8 months ago SCHOTT Pharma Reports Strong Growth and Record Margins for FY 2024 Revenue Growth EBITDA Margin High-value Solutions Drug Delivery Systems Innovation And Expansion
BRIEF published on 12/12/2024 at 07:05, 1 year 8 months ago SCHOTT Pharma annonce une forte croissance et des marges record pour l'exercice 2024 Marge EBITDA Croissance Des Revenus Systèmes D'administration De Médicaments Des Solutions À Haute Valeur Ajoutée Innovation Et Expansion
PRESS RELEASE published on 12/12/2024 at 07:00, 1 year 8 months ago SCHOTT Pharma with strong growth and record margin after solid year-end finish SCHOTT Pharma AG & Co. KGaA reports strong growth and record margin for the fiscal year 2024, meeting 12% revenue growth target and achieving EBITDA margin of 27.8% Innovation Revenue EBITDA Margin SCHOTT Pharma Growth
BRIEF published on 12/04/2024 at 11:05, 1 year 8 months ago SCHOTT Pharma Introduces Efficient and Sustainable Cartridge Nest Design Sustainability GLP-1 Therapies Pharmaceutical Efficiency Cartridge Design Innovative Packaging
Published on 08/18/2026 at 14:30, 20 minutes ago The Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo to Fight the Current Largest Ever and Expanding Ebola Outbreak to Begin Soon
Published on 08/18/2026 at 14:00, 50 minutes ago Lobe Sciences Reports Third Quarter 2026 Financial Results
Published on 08/18/2026 at 13:30, 1 hour 20 minutes ago CANEX Successfully Acquires Gold Basin and Looks to Commence Exploration Activities
Published on 08/18/2026 at 13:10, 1 hour 40 minutes ago Spirit Blockchain Capital Reports Second Quarter 2026 Results & Provides Corporate Update
Published on 08/18/2026 at 13:00, 1 hour 50 minutes ago AIML Subsidiary NeuralCloud Signs Term Sheet with Island Mobile Cardiology Testing for CardioYield(TM) Pilot
Published on 08/18/2026 at 14:35, 15 minutes ago IGEL Advances Business Continuity with Emergency Mode
Published on 08/18/2026 at 14:35, 15 minutes ago EQS-Adhoc: ASTA Energy Solutions AG raises guidance for adjusted EBITDA 2026
Published on 08/18/2026 at 14:35, 15 minutes ago EQS-Adhoc: ASTA Energy Solutions AG raises guidance for adjusted EBITDA 2026
Published on 08/18/2026 at 14:10, 40 minutes ago Nine Ocean Tomo Experts Named to the 2026 IAM Strategy 300 - The World's Leading Intellectual Property Strategists
Published on 08/18/2026 at 14:04, 46 minutes ago Elmos Semiconductor SE: Extraordinary General Meeting elects new members to the Supervisory Board
Published on 08/18/2026 at 11:15, 3 hours 35 minutes ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 10 au 14 août 2026
Published on 08/18/2026 at 11:15, 3 hours 35 minutes ago GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 19 hours 5 minutes ago Aéroports de Paris S.A - July 2026 traffic figures
Published on 08/17/2026 at 19:45, 19 hours 5 minutes ago Aéroports de Paris S.A - Trafic du mois de juillet 2026
